IDEAS home Printed from https://ideas.repec.org/a/spr/drugsa/v47y2024i5d10.1007_s40264-024-01401-z.html
   My bibliography  Save this article

In Utero Exposure to Antibiotics and Risk of Serious Infections in the First Year of Life

Author

Listed:
  • Mylène Tisseyre

    (Hopital Cochin, Assistance Publique-Hopitaux de Paris (AP-HP)
    Université Paris Cité)

  • Mathis Collier

    (Université Paris Cité
    Hopital Cochin, Assistance Publique-Hopitaux de Paris)

  • Nathanaël Beeker

    (Université Paris Cité
    Hopital Cochin, Assistance Publique-Hopitaux de Paris)

  • Florentia Kaguelidou

    (Université Paris Cité
    Hôpital Robert Debré, APHP.Nord)

  • Jean-Marc Treluyer

    (Hopital Cochin, Assistance Publique-Hopitaux de Paris (AP-HP)
    Université Paris Cité
    Hopital Cochin, Assistance Publique-Hopitaux de Paris)

  • Laurent Chouchana

    (Hopital Cochin, Assistance Publique-Hopitaux de Paris (AP-HP)
    Université Paris Cité)

Abstract

Introduction and Objective Given the high prevalence of antibiotic prescription during pregnancy in France and previous studies suggesting an increased risk of infection in offspring with such exposures, our study aimed to investigate the association between prenatal exposure to systemic antibiotics and serious infections in full-term infants during their first year of life. Methods We conducted a retrospective population-based cohort study on singleton, full-term liveborn non-immunocompromised infants, using the French National Health Data System (SNDS) between 2012 and 2021. Systemic antibiotic dispensing in ambulatory care settings during pregnancy defined the exposure. Outcomes concerned serious infections (i.e., infections requiring hospitalization) in offspring identified between 3 and 12 months of life, hence excluding infections of maternal origin. Adjusted odds ratios (aORs) were estimated using logistic regression with multivariate models to control for potential confounders. Results Of 2,836,630 infants included, 39.6% were prenatally exposed to systemic antibiotics. Infants prenatally exposed to antibiotics had a higher incidence of serious infections compared with unexposed infants {aOR 1.12 [95% confidence interval (95% CI) 1.11–1.13]}. Similar associations were observed according to the timing of exposure during pregnancy, antibiotic class, and site of infections. The strongest association was observed when infants were prenatally exposed to three or more antibiotic courses during pregnancy [aOR 1.21 (95% CI 1.19–1.24)]. Limitations include residual confounders, such as genetic susceptibility to infections and the role of the underlying pathogen agent. Conclusion Prenatal exposure to systemic antibiotics is very common and is associated with a weak yet significant associations with subsequent serious infectious events during the first year of life. While our study revealed associations, it is important to note that causation cannot be established, given the acknowledged limitations, including potential confounding by indication.

Suggested Citation

  • Mylène Tisseyre & Mathis Collier & Nathanaël Beeker & Florentia Kaguelidou & Jean-Marc Treluyer & Laurent Chouchana, 2024. "In Utero Exposure to Antibiotics and Risk of Serious Infections in the First Year of Life," Drug Safety, Springer, vol. 47(5), pages 453-464, May.
  • Handle: RePEc:spr:drugsa:v:47:y:2024:i:5:d:10.1007_s40264-024-01401-z
    DOI: 10.1007/s40264-024-01401-z
    as

    Download full text from publisher

    File URL: http://link.springer.com/10.1007/s40264-024-01401-z
    File Function: Abstract
    Download Restriction: Access to the full text of the articles in this series is restricted.

    File URL: https://libkey.io/10.1007/s40264-024-01401-z?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:drugsa:v:47:y:2024:i:5:d:10.1007_s40264-024-01401-z. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com/economics/journal/40264 .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.